Biosense Webster announced positive one-year results from multiple studies evaluating its Varipulse pulsed field ablation (PFA) system. Johnson & Johnson MedTech’s electrophysiology unit shared results from its inspIRE and admIRE studies. The inspIRE study looked at pulmonary vein isolation using a variable loop catheter with 3D mapping integration. The admIRE study used a variable loop […]
Johnson & Johnson
10 surgical robotics companies you need to know
The surgical robotics space saw a major shakeup last year. “Robotics is hard. Robotics in healthcare is hard.” Hani Abouhalka, Johnson & Johnson’s company group chair for Robotics & Digital, said those words at our DeviceTalks West event in California in October. It pretty much sums up the situation for medtech companies large and small […]
Study backs Biosense Webster low/zero fluoroscopy AFib ablation
Johnson & Johnson MedTech’s Biosense Webster announced positive findings from real-world data looking at its AFib ablation technology. The study evaluated the safety and effectiveness of low/zero fluoroscopy AFib ablation. Results supported the use of workflows to reduce radiation exposure during catheter ablation for treating paroxysmal AFib. Data also showed sustained safety, efficacy and long-term […]
Johnson & Johnson MedTech reports 13% sales uptick in Q4, has positive ablation outlook
Johnson & Johnson reported more MedTech growth as its fourth-quarter results came in slightly ahead of the consensus forecast. Shares of JNJ were down more than 2% to $158.68 apiece in morning trading. MassDevice‘s MedTech 100 Index was down slightly. The New Brunswick, New Jersey-based company posted profits of $4.1 billion. That equals $1.70 per share on […]
The biggest stories from the 2024 J.P. Morgan Healthcare Conference
Some of the biggest names in medtech came together this week at the J.P. Morgan Healthcare Conference. They shared updates on financial progress, operational changes and new products, among other things. Medtronic shared details on plans to restore earnings power, while Abbott highlighted the success of its FreeStyle Libre system. Shockwave Medical outlined its plans […]
J&J’s Acclarent wins FDA nod for pediatric ear tube balloon dilation system
Johnson & Johnson MedTech unit Acclarent announced that it won a new FDA clearance for its Aera Eustachian tube balloon dilation system. While Acclarent still belongs to Johnson & Johnson, Integra Lifesciences is set to buy it for $275 million next year. While the completion of that deal awaits, the company cleared a regulatory hurdle […]
The top medtech trends of 2023
The top medtech trends of 2023 included innovations such as artificial intelligence, new GLP-1 weight loss drugs and some long-awaited medtech finally receiving regulatory nods. With health providers facing additional challenges on top of an ever-uncertain economic environment, medtech companies also made major readjustments: layoffs, spinoffs, reorganizations and much more. Here are the top stories […]
J&J’s Biosense Webster treats first patients in dual-energy AFib ablation trial
Johnson & Johnson’s Biosense Webster today announced the first completed patient cases in a study of its dual-energy ablation catheter. Biosense Webster designed the ThermoCool SmartTouch SF to deliver both radiofrequency (RF) and pulsed-field ablation (PFA) energy. The SmartPulse pivotal study evaluates the dual-energy system in the treatment of paroxysmal AFib. AFib ablation has become […]
Former J&J MedTech head Ashley McEvoy takes board role at consumer goods giant
Less than two months after announcing her departure from Johnson & Johnson MedTech, Ashley McEvoy has taken on a role on the board of Procter & Gamble. In October, the former EVP and worldwide chair at J&J MedTech announced her intention to leave the world’s second-largest medical device manufacturer. Tim Schmid took over the position […]
Integra LifeSciences to buy Johnson & Johnson’s Acclarent and its ENT tech
Integra LifeSciences announced today that it entered into a definitive agreement to acquire Acclarent from Johnson & Johnson MedTech. Acclarent, part of J&J MedTech’s Ethicon unit, enhances Integra’s position in the ear, nose and throat (ENT) treatment market. Integra already offers the MicroFrance line of ENT instruments. The company believes that, upon closing, the deal […]
Johnson & Johnson’s Ethicon settles more Physiomesh suits
Johnson & Johnson has settled more than 200 cases remaining in a multi-district litigation over hernia mesh made by its Ethicon subsidiary. U.S. District Court Judge Richard Story in Northern Georgia on Dec. 1 agreed to dismiss the cases with prejudice at the request of lawyers for both sides. The lawyers had informed him that […]